Book profits on Sun Pharma, Dr Reddy's: Ajay Srivastava, Dimensions Consulting

In a chat with ET Now, Ajay Srivastava, CEO, Dimensions Consulting, shares his views on Pharma stocks.

ET Now: What about names from the pharma space the likes of a Dr. Reddy’s or Sun Pharma is it time to book out there or is there still money to be made in these names?

Ajay Srivastava: It is very wise to book profits in this market because of the simple reason that market is giving opportunities to buy the stocks again. Yes, you keep seeing the highs but also intermediately you will find selling in Sun Pharma, selling in Dr Reddy’s which comes around but typically you would tend to build on it.

There is still money to be made in the stocks, these stocks will enjoy good multiple rupee at 62, their export business is going to get them phenomenal returns at this point of time.

So you do not want to sell out these stocks at all. Only reason you sell out is book profit and see that you buy back again, do not liquidate them from a portfolio, they will give you 20-25% return year on year for the years to come.